SCHEMBL24205477

SCHEMBL24205477

C=C(C)C(=O)OCCCCCCCOc1ccc2c(C)cc(=O)oc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.60
MAOA P21397 2/20 0.60
ALDH1A1 P00352 6/20 0.60
KMT2A Q03164 3/20 0.60
MAPT P10636 2/20 0.60
HPGD P15428 2/20 0.60
HSD17B10 Q99714 2/20 0.60
TP53 P04637 1/20 0.60
KDM4E B2RXH2 6/20 0.56
GLA P06280 3/20 0.56
GAA P10253 3/20 0.56
MEN1 O00255 2/20 0.56
AR P10275 1/20 0.56
RAB9A P51151 1/20 0.56
L3MBTL1 Q9Y468 2/20 0.53
ACHE P22303 3/20 0.53
TSHR P16473 1/20 0.53
ALDH2 P05091 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
POLB P06746 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7914303 1.00 MAOB (0.60) MAOBMAOAALDH1A1KMT2AMAPT
SCHEMBL7914328 0.99 MAOB (0.61) MAOBMAOAALDH1A1KMT2AMAPT
SCHEMBL7914330 0.97 ALDH1A1 (0.61) MAOBMAOAALDH1A1KMT2AMAPT
SCHEMBL7920778 0.93 ALDH1A1 (0.62) MAOBMAOAALDH1A1KMT2AMAPT
SCHEMBL29408446 0.93 ALDH1A1 (0.62) MAOBMAOAALDH1A1KMT2AMAPT
SCHEMBL7907388 0.90 ALDH1A1 (0.60) MAOBMAOAALDH1A1KMT2AMAPT
SCHEMBL7907365 0.85 KDM4E (0.61) MAOBMAOAALDH1A1KMT2AHPGD
SCHEMBL7920960 0.85 AGER (0.60) MAOBALDH1A1KMT2AHPGDKDM4E
SCHEMBL28598939 0.84 MAOB (0.60) MAOBMAOAALDH1A1KMT2AMAPT
SCHEMBL17439465 0.84 ALDH1A1 (0.61) ALDH1A1KMT2AMAPTHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4182737-B1 OPTICALLY ACTIVE DEVICES AMO Ireland (IE) 2024-07-03 EP disclosed
US-20230273455-A1 OPTICALLY ACTIVE DEVICES JOHNSON & JOHNSON SURGICAL VISION INC (US) 2023-08-31 US disclosed
US-20230273456-A1 OPTICALLY ACTIVE DEVICES JOHNSON & JOHNSON SURGICAL VISION INC (US) 2023-08-31 US disclosed
WO-2022012798-A1 OPTICALLY ACTIVE DEVICES MERCK PATENT GMBH (DE) 2022-01-20 WO disclosed
WO-2022012799-A1 OPTICALLY ACTIVE DEVICES MERCK PATENT GMBH (DE) 2022-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230273456-A1 OPTICALLY ACTIVE DEVICES PDE6C, PDE6D, PDE6A MAOB 403/4885MAOA 237/4885ALDH1A1 277/4885
US-20230273455-A1 OPTICALLY ACTIVE DEVICES PDE6C, PDE6A, PDE6D MAOB 404/4885MAOA 241/4885ALDH1A1 311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.